English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

recurrent primary and systemic malignancies with CNS metastasis Lyndon Kim, MD1,2, Kevin Judy, MD1, James Evans, MD1, Christopher Farrell, MD1 and David Andrews, MD1, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA Department of Neurological Surgery1 and Medical Oncology2 Sidney Kimmel Medical College at Thomas Jefferson University Hospital, Philadelphia, PA 19107

neuro-oncology

MPTH-58. PEMETREXED: A POTENTIAL NEW THERAPEUTIC OPTION FOR THE TREATMENT OF THYMIDYLATE SYNTHASE (TS) NEGATIVE RECURRENT PRIMARY AND SYSTEMIC MALIGNANCIES WITH CNS METASTASIS